Amphetamine use disorder phenotype
Evidence from:
primary |
all sources
Related entities (2)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| mood disorders | associated_with | Amphetamine use disorder | — | 1 |
| naltrexone | protective_against | Amphetamine use disorder | — | 1 |
Mentioned in (5)
Papers in which this entity is mentioned.
- Multi-environment gene interactions linked to the interplay between polysubstance dependence and suicidality. (2021)
- Genome-wide association analysis of opioid use disorder: A novel approach using clinical data. (2020)
- Prevalence of DSM-IV and DSM-5 alcohol, cocaine, opioid, and cannabis use disorders in a largely substance dependent sample. (2013)
- The genetics of the opioid system and specific drug addictions. (2012)
- Psychiatric comorbidity in methamphetamine dependence. (2011)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| amphetamine use disorder | phenotype | 3 | 3 |
| amphetamine dependence | phenotype | 2 | 2 |
| amphetamine | phenotype | — | — |